Leucine
In clinical developmentAlso known as (2S)-2-Amino-4-methylpentanoic acid, (2S)-alpha-2-Amino-4-methylvaleric acid, (2S)-alpha-Leucine, (S)-(+)-Leucine+45 more
(2S)-2-Amino-4-methylpentanoic acid, (2S)-alpha-2-Amino-4-methylvaleric acid, (2S)-alpha-Leucine, (S)-(+)-Leucine, (S)-Leucine, 2-Amino-4-methylvaleric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Branchamin, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, L, L-Leucin, L-Leucine, L-Leuzin, Leu, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25.
Recent clinical, regulatory, research and industry developments relating to this drug.
An Experimental Treatment Approach for Inflammation-Induced Depression
The Effect of Lidocaine to Prevent the Development of Chronic Post-Surgical Pain
Collaborative Research Group for Necrotizing Enterocolitis
The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Journals, researchers & institutions
- eLife1
- Nucleic acids research1
- Begley T1
- Butler RM1
- Chen D1
- Choudhuri JV1
- Chuang HY1
- Cohoon M1
- de Crécy-Lagard V1
- Diaz N1
- Key Laboratory of Animal Disease Resistance Nutrition of China Ministry of Education1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials